Colon cancer arising in an ulcer scar due to intestinal Behçet's disease

Internal Medicine

Volumn 50, Issue 5, 2011, Pages 429-432

  Yamada, Masayoshi ^a   Shiroeda, Hisakazu ^a   Nomura, Tomoe ^a   Hayashi, Ranji ^a   Sato, Katsuaki ^a   Tsutsumi, Mikihiro ^a   Arisawa, Tomiyasu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Beh et's disease; Colon cancer; Human MutL protein homolog1; K ras; p53

Indexed keywords

BETA CATENIN; C REACTIVE PROTEIN; COLCHICINE; DIATRIZOATE; PROTEIN MLH1;

ABDOMINAL DISTENSION; AGED; APHTHOUS ULCER; ARTICLE; BEHCET DISEASE; CANCER INVASION; CASE REPORT; COLON ADENOCARCINOMA; COLONOSCOPY; FOLLOW UP; GENE MUTATION; GENITAL ULCER; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; ILEUS; IMMUNOHISTOCHEMISTRY; INTESTINAL FIBROSIS; INTESTINE ULCER; MALE; NUCLEIC ACID BASE SUBSTITUTION; TUMOR SUPPRESSOR GENE; UVEITIS;

AGED; BASE SEQUENCE; BEHCET SYNDROME; CICATRIX; CODON, NONSENSE; COLONIC NEOPLASMS; DNA, NEOPLASM; GENES, P53; HUMANS; INTESTINAL DISEASES; MALE; SEQUENCE DELETION; ULCER;

EID: 79952323054     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4434     Document Type: Article

References (10)

1. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease. Int J Dermatol 42: 346-351, 2003.
2. Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study. Br J Dermatol 157: 901-906, 2007.
3. Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T. Intestinal involvement in Behçet's disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum 24: 103-106, 1981.
4. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126: 451-459, 2004.
5. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology 130: 1039-1046, 2006.
6. Cengiz M, Altundag MK, Zorlu AF, Gullu IH, Ozyar E, Atahan IL. Malignancy in Behçet's disease: a report of 13 cases and a review of the literature. Clin Rheumatol 20: 239-244, 2001.
7. Lennard-Jones JE, Morson BC, Ritchie JK, Shove DC, Williams CB. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology 73: 1280-1289, 1977.
8. Hussain SP, Amstad P, Raja K, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancerprone chronic inflammatory disease. Cancer Res 60: 3333-3337, 2000.
9. Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57: 808-811, 1997.
10. Hiesse C, Kriaa F, Rieu P, et al. Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine-treated recipients: analysis of a 20-year period in 1600 patients. Transplant Proc 27: 972-974, 1995.